CLINICAL TRIALS PROFILE FOR TECHNETIUM TC-99M SESTAMIBI KIT

All Clinical Trials for TECHNETIUM TC-99M SESTAMIBI KIT

Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00162045 ↗	A Trial to Determine Radiation Exposure to Organs and Assess the Safety of CARDIOLITE® in Pediatric Subjects	Completed	Lantheus Medical Imaging	Phase 1/Phase 2	2005-01-01	The purpose of this Phase I-II multicenter clinical trial is to establish dosimetry and safety profiles for CARDIOLITE® (Technetium Tc99m Sestamibi) in pediatric subjects.
NCT00162071 ↗	A Phase II Optimization Study of BMS068645 and Sestamibi Planar Imaging	Terminated	Forest Laboratories	Phase 2	2005-07-01	The primary purpose of this study is to determine the optimal time for myocardial perfusion imaging with Technetium Tc99m Sestamibi following the administration of BMS068645. The safety of BMS068645 will also be studied.
NCT00560495 ↗	Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer	Withdrawn	National Cancer Institute (NCI)	Phase 1	2007-05-01	RATIONALE: Ammonium tetrathiomolybdate may stop the growth of non-small cell lung cancer by blocking blood flow to the tumor. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving ammonium tetrathiomolybdate together with radiation therapy may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects of giving radiation therapy together with ammonium tetrathiomolybdate in treating patients with stage I, stage II, or stage III non-small cell lung cancer.
NCT00560495 ↗	Radiation Therapy and Ammonium Tetrathiomolybdate in Treating Patients With Stage I, Stage II, or Stage III Non-Small Cell Lung Cancer	Withdrawn	Roswell Park Cancer Institute	Phase 1	2007-05-01	RATIONALE: Ammonium tetrathiomolybdate may stop the growth of non-small cell lung cancer by blocking blood flow to the tumor. Radiation therapy uses high-energy x-rays to kill tumor cells. Giving ammonium tetrathiomolybdate together with radiation therapy may kill more tumor cells. PURPOSE: This phase I trial is studying the side effects of giving radiation therapy together with ammonium tetrathiomolybdate in treating patients with stage I, stage II, or stage III non-small cell lung cancer.
NCT00767468 ↗	Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis	Terminated	National Cancer Institute (NCI)	Phase 1	2008-10-01	RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase I trial is studying the side effects and best dose of sorafenib in treating patients with locally advanced or metastatic liver cancer and cirrhosis.
NCT00767468 ↗	Sorafenib in Treating Patients With Locally Advanced or Metastatic Liver Cancer and Cirrhosis	Terminated	UNC Lineberger Comprehensive Cancer Center	Phase 1	2008-10-01	RATIONALE: Sorafenib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth and by blocking blood flow to the tumor. PURPOSE: This phase I trial is studying the side effects and best dose of sorafenib in treating patients with locally advanced or metastatic liver cancer and cirrhosis.

Clinical Trial Conditions for TECHNETIUM TC-99M SESTAMIBI KIT

Condition Name

Condition Name for TECHNETIUM TC-99M SESTAMIBI KIT
Intervention	Trials
Ischemic Heart Disease	1
Kawasaki Disease	1
Liver Cancer	1
Lung Cancer	1

Condition MeSH

Condition MeSH for TECHNETIUM TC-99M SESTAMIBI KIT
Intervention	Trials
Syndrome	2
Carcinoma, Hepatocellular	1
Breast Neoplasms	1
Mucocutaneous Lymph Node Syndrome	1

Clinical Trial Locations for TECHNETIUM TC-99M SESTAMIBI KIT

Trials by Country

Trials by Country for TECHNETIUM TC-99M SESTAMIBI KIT
Location	Trials
United States	13
Taiwan	1
Canada	1

Trials by US State

Trials by US State for TECHNETIUM TC-99M SESTAMIBI KIT
Location	Trials
Minnesota	2
New York	2
North Carolina	1
Wisconsin	1
Washington	1

Clinical Trial Progress for TECHNETIUM TC-99M SESTAMIBI KIT

Clinical Trial Phase

Clinical Trial Phase for TECHNETIUM TC-99M SESTAMIBI KIT
Clinical Trial Phase	Trials
Phase 4	1
Phase 2	2
Phase 1/Phase 2	1

Clinical Trial Status

Clinical Trial Status for TECHNETIUM TC-99M SESTAMIBI KIT
Clinical Trial Phase	Trials
Completed	3
Terminated	2
Withdrawn	1

Clinical Trial Sponsors for TECHNETIUM TC-99M SESTAMIBI KIT

Sponsor Name

Sponsor Name for TECHNETIUM TC-99M SESTAMIBI KIT
Sponsor	Trials
National Cancer Institute (NCI)	3
Mayo Clinic	2
Lantheus Medical Imaging	1

Sponsor Type

Sponsor Type for TECHNETIUM TC-99M SESTAMIBI KIT
Sponsor	Trials
NIH	5
Other	5
Industry	3